The American Journal of Gastroenterology

To stent or not to stent?
pp. 1857-1859(3)
Author: McGrath, K.M.

Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease
pp. 1859-1861(3)
Author: O'Brien, J.

Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy
pp. 1861-1862(2)
Authors: Fong, D.G.; Lindor, K.D.

Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know
pp. 1862-1864(3)
Author: Grace, N.D.

Gastroesophageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable?
pp. 1868-1872(5)
Authors: Bohmer, C.J.M.; Klinkenberg-Knol, E.C.; Niezen-de Boer, M.C.; Meuwissen, S.G.M.

Fecal incontinence: a practical approach to evaluation and treatment
pp. 1873-1880(8)
Authors: Soffer, E.E.; Hull, T.

Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus
pp. 1881-1887(7)
Authors: Eloubeidi, M.A.; Provenzale, D.

Long-term follow-up of Barrett's high-grade dysplasia
pp. 1888-1893(6)
Authors: Weston, A.P.; Sharma, P.; Topalovski, M.; Richards, R.; Cherian, R.; Dixon, A.

Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: A double-blind, randomized clinical trial
pp. 1894-1899(6)
Authors: Farley, A.; Wruble, L.D.; Humphries, T.J.

The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome
pp. 1900-1905(6)
Authors: Su, Y.; Wang, W.; Wang, S.; Lu, S.; Chen, L.; Wu, D.; Chen, C.; Jan C.-M.,; Horowitz, M.

Helicobacter pylori and dyspepsia: a population-based study of the organism and host
pp. 1906-1913(8)
Authors: Locke, G.R.; Talley, N.J.; Nelson, D.K.; Haruma, K.; Weaver, A.L.; Zinsmeister, A.R.; Melton, L.J.

A survey of internal medicine residents' knowledge about Helicobacter pylori infection¹
pp. 1914-1919(6)
Authors: Sharma, V.K.; Bailey, D.M.; Raufman, J.; Elraie, K.; Metz, D.C.; Go, M.F.; Schoenfeld, P.; Smoot, D.T.; Howden, C.W.

Are self-expanding metal mesh stents useful in the treatment of benign esophageal stenoses and fistulas? An experience of four cases
pp. 1920-1925(6)
Authors: Lee, J.G.; Hsu, R.; Leung, J.W.

Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma
pp. 1926-1931(6)
Authors: Ahmad, N.A.; Lewis, J.D.; Siegelman, E.S.; Rosato, E.F.; Ginsberg, G.G.; Kochman, M.L.

A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency
pp. 1932-1938(7)
Authors: Stern, R.C.; Eisenberg, J.D.; Wagener, J.S.; Ahrens, R.; Rock, M.; doPico, G.; Orenstein, D.M.

Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer
pp. 1939-1945(7)
Authors: Yamaguchi, K.; Chijiiwa, K.; Torato, N.; Kinoshita, R.T.M.; Tanaka, M.

Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease
pp. 1946-1948(3)
Authors: Bonner, G.F.; Walczak, M.; Kitchen, L.; Bayona, M.

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study
pp. 1949-1954(6)
Authors: Felder, J.B.; Korelitz, B.I.; Rajapakse, R.; Schwarz, S.; Horatagis, A.P.; Gleim, G.

Annual cost of care for Crohn's disease: a payor perspective
pp. 1955-1960(6)
Authors: Feagan, B.G.; Vreeland, M.G.; Larson, L.R.; Bala, M.V.

A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients
pp. 1961-1966(6)
Authors: Khan, A.M.; Birk, J.W.; Anderson, J.C.; Georgsson, M.; Park, T.L.; Smith, C.J.; Comer, G.M.

Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis
pp. 1967-1973(7)
Authors: Yao, K.; Yao, T.; Iwashita, A.; Matsui, T.; Kamachi, S.

High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome¹
pp. 1974-1982(9)
Authors: Fine, K.D.; Do, K.; Schulte, K.; Ogunji, F.; Guerra, R.; Osowski, L.; McCormack, J.

Indium-111 leukocyte scintigraphy in suspected bowel ischemia
pp. 1983-1989(7)
Authors: Dhekne, R.D.; Chatziioannou, S.N.; Moore, W.H.; Ford, P.V.; Hochman, F.L.

Colonic inflammation found at diagnosis of juvenile retention polyps in pediatric patients
pp. 1990-1993(4)
Authors: Kader, H.A.; Wenner, W.J.; Baldassano, R.N.; Ruchelli, E.; Carpentieri, D.F.; Verma, R.; Mascarenhas, M.R.

Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease
pp. 1994-1999(6)
Authors: Schottelius, A.; Wedel, S.; Weltrich, R.; Rohde, W.; Buttgereit, F.; Schreiber, S.; Lochs, H.

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis
pp. 2000-2008(9)
Authors: Rowe, F.A.; Walker, J.H.; Karp, L.C.; Vasiliauskas, E.A.; Plevy, S.E.; Targan, S.R.

Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis
pp. 2009-2014(6)
Authors: Koop, I.; Ilchmann, R.; Izzi, L.; Adragna, A.; Koop, H.; Barthelmes, H.

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study
pp. 2015-2022(8)
Authors: van Hoogstraten, H.J.F.; Vleggaar, F.P.; Boland, G.J.; van Steenbergen, W.; Griffioen, P.; Hop, W.C.J.; van Hattum, J.; van Berge Henegouwen, G.P.; Schalm, S.W.; van Buuren, H.R.

Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation
pp. 2023-2028(6)
Authors: de, B.K.; Sen, S.; Biswas, P.K.; Sengupta, D.; Biswas, J.; Santra, A.; Hazra, B.; Maity, A.K.

The prognostic significance of subclinical hepatic encephalopathy
pp. 2029-2034(6)
Authors: Hartmann, I.J.C.; Groeneweg, M.; Quero, J.C.; Beijeman, S.J.; de Man, R.A.; Hop, W.C.J.; Schalm, S.W.

Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay
pp. 2035-2039(5)
Authors: Rosen, H.R.; Gretch, D.; Kaufman, E.; Quan, S.

Significance of soluble TNF receptor-I in acute-type fulminant hepatitis
pp. 2040-2046(7)
Authors: Tokushige, K.; Yamaguchi, N.; Ikeda, I.; Hashimoto, E.; Yamauchi, K.; Hayashi, N.

Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure
pp. 2047-2055(9)
Authors: Ryo, K.; Kamogawa, Y.; Ikeda, I.; Yamauchi, K.; Yonehara, S.; Nagata, S.; Hayashi, N.

Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C
pp. 2056-2060(5)
Authors: Brandhagen, D.J.; Gross, J.B.; Poterucha, J.J.; Germer, J.J.; Czaja, A.J.; Smith, C.I.; Ribeiro, A.C.; Guerrero, R.B.; Therneau, T.M.; Schiff, E.; Gordon, F.D.; Wiesner, R.H.; Persing, D.H.

Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis
pp. 2061-2067(7)
Authors: Ockenga, J.; Stuhrmann, M.; Ballmann, M.; Teich, N.; Keim, V.; Dork, T.; Manns, M.P.

Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance
pp. 2068-2073(6)
Authors: Sharma, V.K.; Corder, F.A.; Raufman, J.; Sharma, P.; Fennerty, M.B.; Howden, C.W.

A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy - A comparison of sequential sigmoidoscopy and colonoscopy with immediate conversion from sigmoidoscopy to colonoscopy in patients with an abnormal screening sigmoidoscopy
pp. 2074-2079(6)
Authors: Stern, M.A.; Fendrick, A.M.; McDonnell, W.M.; Gunaratnam, N.; Moseley, R.; Chey, W.D.

Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma
pp. 2080-2085(6)
Authors: Yatsuoka, T.; Sunamura, M.; Furukawa, T.; Fukushige, S.; Yokoyama, T.; Inoue, H.; Shibuya, K.; Takeda, K.; Matsuno, S.; Horii, A.

Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?
pp. 2086-2093(8)
Authors: Soni, A.; Sampliner, R.E.; Sonnenberg, A.

Hemorrhoid clamp
pp. 2094-2094(1)
Author: Kravetz, R.E.

Successful treatment of cap polyposis by avoidance of intraluminal trauma: clues to pathogenesis
pp. 2095-2098(4)
Authors: Oriuchi, T.; Kinouchi, Y.; Kimura, M.; Hiwatashi, N.; Hayakawa, T.; Watanabe, H.; Yamada, S.; Nishihira, T.; Ohtsuki, S.; Toyota, T.

Liver pseudotumor: a rare manifestation of hepatic granulomata caused by ascaris lumbricoides ova
pp. 2099-2101(3)
Authors: Fogaca, H.S.; Oliveira, C.S.; Barbosa, H.T.; Lanfredi, R.M.; Chagas, V.

CT-guided treatment of ultrasonically invisible hepatocellular carcinoma
pp. 2102-2106(5)
Authors: Sato, M.; Watanabe, Y.; Tokui, K.; Kawachi, K.; Sugata, S.; Ikezoe, J.

The pitfall of relying on the abdominal radiograph to determine stent function after palliation of malignant colonic obstruction using a self-expanding metal stent
pp. 2107-2109(3)
Authors: Lee, J.G.; Leung, J.W.

Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum
pp. 2110-2115(6)
Authors: Ponz de Leon, M.; Benatti, P.; Pedroni, M.; Viel, A.; Genuardi, M.; Percesepe, A.; Roncucci, L.

Congenital bronchoesophageal fistula in the adult: a case report¹
pp. 2116-2118(3)
Authors: Cossentino, M.J.; Ormseth, E.J.; Tavaf-Motamen, H.; Cheney, C.P.

''Congenital'' esophageal stenosis, corrugated ringed esophagus, and eosinophilic esophagitis
pp. 2123-2123(1)
Author: Langdon, D.E.

Seroepidemiology of Helicobacter pylori and hepatitis A virus
pp. 2124-2125(2)
Authors: Furuta, T.; Shirai, N.; Takashima, M.; Xiao, F.; Kaneko, E.; Hanai, H.

Response to Dr. Langdon
pp. 2124-2124(1)
Author: Katzka, D.A.

Response to Dr. Furuta et al.
pp. 2125-2126(2)
Authors: Fujisawa, T.; Akamatsu, T.; Kiyosawa, K.; Kumagai, T.; Matsunaga, Y.

Spontaneous bacterial peritonitis and bacteremia in fulminant hepatic failure
pp. 2126-2126(1)
Author: Chu C.-M.,

Response to Dr. Chu
pp. 2127-2128(2)
Authors: Dhiman, R.K.; Chawla, Y.; Jain, S.

Re: probiotics and C. difficile diarrhea
pp. 2128-2128(1)
Author: McFarland, L.V.

Response to Dr. McFarland
pp. 2128-2128(1)
Author: Vanderhoof, J.A.

Patient knowledge in inflammatory bowel disease
pp. 2128-2129(2)
Authors: O'Sullivan, M.; O'Morain, C.

Risk factors in irritable bowel syndrome
pp. 2129-2130(2)
Author: Hunt, S.C.

Risk factor for irritable bowel syndrome: role of food allergies
pp. 2130-2131(2)
Authors: Addolorato, G.; Capristo, E.; Ghittoni, G.; Ancona, C.; Gasbarrini, G.

Re: melanoma in the GI tract
pp. 2131-2131(1)
Authors: Newman, J.L.; Hemmings, M.B.; Watkins, S.P.

Helicobacter pylori and gastric cancer
pp. 2131-2133(3)
Authors: Testino, G.; Valentini, M.; Cornaggia, M.

Experience and volume: the ingredients for successful therapeutic endoscopic outcomes, especially ERCP and postgastrectomy patients
pp. 2133-2134(2)
Authors: Siegel, J.H.; Cohen, S.A.; Kasmin, F.E.

Innovative thinking for the improvement of medical systems-''ENDOVIEW for the patients''
pp. 2134-2134(1)
Authors: Gardner, A.; Raju, G.S.

Activation of epidermal growth factor receptor kinase in gastric carcinoma: a preliminary study
pp. 2135-2136(2)
Authors: Masaki, T.; Hatanaka, Y.; Nishioka, M.; Tokuda, M.; Shiratori, Y.; Reginfo, W.; Omata, M.

A novel device for colonoscopic tube decompression
pp. 2136-2136(1)
Authors: Yarze, J.C.; Winchell, E.C.; Brooks, R.L.

A high anti-HBs response in Turkish students of nursing with inexpensive, multidose vial hepatitis B vaccine
pp. 2137-2137(1)
Authors: Doganci, L.; Saracli, M.A.; Guney, C.

Rectal syndrome as first presentation of metastatic breast cancer
pp. 2138-2139(2)
Authors: Nieboer, P.; van der Graaf, W.T.A.; de Knegt, R.J.; van Dullemen, H.M.

Umbilical hemorrhage from a cutaneous varix treated by transjugular intrahepatic portosystemic shunt (TIPS)
pp. 2139-2140(2)
Authors: Hassoun, Z.; Pomier-Layrargues, G.; Lafortune, M.; Perreault, P.; Gianfelice, D.; Bui, B.; Lepanto, L.

Chronic diarrhea: identifying a new syndrome
pp. 2140-2141(2)
Author: Habba, S.F.

Didanosine-induced hepatitis
pp. 2141-2143(3)
Authors: Ware, A.J.; Berggren, R.A.; Taylor, W.E.

''Giant'' colon lipoma-to attempt endoscopic resection or not?
pp. 2143-2144(2)
Authors: Chase, M.P.; Yarze, J.C.

High biotinidase activity in type Ia glycogen storage disease
pp. 2144-2144(1)
Authors: Saltik, I.N.; Ozen, H.; Kocak, N.; Yuce, A.; Gurakan, F.

Calcium channel blockers and hepatotoxicity
pp. 2145-2145(1)
Authors: Lafuente, N.G.; Egea, A.M.

Centenarians and Helicobacter pylori
pp. 2145-2146(2)
Authors: Luzza, F.; Costa, M.C.; Mattace, R.; Pallone, F.

Total proctocolectomy and ileal pouch anal anastomosis to successfully treat a patient with collagenous colitis
pp. 2147-2147(1)
Authors: Williams, R.A.; Gelfand, D.V.

Intestinal nodular lymphoid hyperplasia in a patient with chronic diarrhea and recurrent sinopulmonary infections
pp. 2147-2149(3)
Authors: Al Samman, M.; Zuckerman, M.J.; Mohandas, A.; Hoffpauir, J.T.; Ting, S.

Breast metastasis of primary colon cancer
pp. 2149-2149(1)
Authors: Ozakyol, A.H.; Saricam, T.; Isiksoy, S.